About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
NVCR - NovoCure Limited| Previous Close | $148.90 | Open | $142.02 |
| Volume | 581.3K | Market Cap | 17.624B |
| Yield | Last Dividend |
| The Daily Biotech Pulse: DermTech Soars ... | 02/11/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X... | |
| The Daily Biotech Pulse: Lilly COVID-19 ... | 02/10/21 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 M... | |
| Novocure Announces Addition to Its Board... | 02/08/21 |
| ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR--Timothy J. Scannell, President and Chief Operating Officer of Stryker Corporation, has been elected to ... | |
| Healthcare hedge fund Rhenman gauges ???... | 01/14/21 |
| Healthcare hedge fund Rhenman gauges ???crucial??? impact of Biden administration???s planned reforms Submitted By Hugh Leask | 14/01/2021 - 1:07pm Th... | |
| Novocure Announces Fourth Quarter and Fu... | 01/11/21 |
| ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR--Novocure reported operating statistics and preliminary, unaudited net revenues and cash balances for th... | |
| Novocure Could Weaken Further in the Day... | 01/04/21 |
| NovoCure Stock Could Weaken Further in the Days Ahead???NVCR | |
| The Daily Biotech Pulse: FDA Nod For Amp... | 12/29/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 28) Acl... | |
| Insider Selling: NovoCure Limited (NASDA... | 12/25/20 |
| NovoCure Limited (NASDAQ:NVCR) CEO Asaf Danziger sold 207,910 shares of NovoCure stock in a transaction dated Friday, December 18th. The shares were s... | |
| Novocure Announces National Reimbursemen... | 12/14/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure announced national reimbursement in Switzerland for Optune in combination with temozolomide for the trea... | |
| J.P. Morgan Stick to Their Hold Rating f... | 12/11/20 |
| J.P. Morgan Stick to Their Hold Rating for NovoCure Ltd | |
| Novocure to Participate in the Evercore ... | 11/25/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure will participate in the 3rd Annual Evercore ISI 2020 Virtual HealthCONx Conference on December 1 through... | |
| Novocure : Announces 43 Presentations on... | 11/19/20 |
| Presentations on Tumor Treating Fields cover a broad and growing range of topics, with nearly 85 percent of presentations prepared by external authors... | |
| Novocure Announces 43 Presentations on T... | 11/19/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure announced 43 presentations on Tumor Treating Fields will be featured at the Society for Neuro-Oncology 2... | |
| Novocure Receives CE Mark for NovoTTF-10... | 11/11/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure has received the CE mark for the NovoTTF-100L system, enabling commercialization of the device to treat ... | |
| Novocure Announces Closing of $150 Milli... | 11/09/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure announced the closing of a new $150 million revolving credit facility with a syndicate of relationship b... | |
| How to Play NovoCure Stock Right Now | 11/04/20 |
| How to Play NovoCure Stock Right Now???NVCR | |
| Cramer Weighs In On Fisker, Novocure And... | 11/03/20 |
| On CNBC's "Mad Money Lightning Round," Jim Cramer said Fisker Inc (NYSE: FSR ) is a decent spec. Cramer is willing to endorse ??? Full story available... | |
| Novocure Prices $500 Million 0% Converti... | 11/02/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR--Novocure prices $500 million 0% convertible senior notes through a private placement. | |
| Novocure Announces Proposed Private Plac... | 11/02/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure today announced its intention to offer $500 million aggregate principal amount of Convertible Senior Not... | |
| NovoCure (NVCR) Q3 2020 Earnings Call Tr... | 10/29/20 |
| NVCR earnings call for the period ending September 30, 2020. | |
| Novocure Earnings and Growth Analysis : ... | 10/29/20 |
| Novocure announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| Novocure Reports Third Quarter 2020 Fina... | 10/29/20 |
| ST. HELIER, Jersey--(BUSINESS WIRE)---- $NVCR #earnings--Novocure reported financial results for the quarter ended September 30, 2020, and provided a ... | |
| Novocure (NASDAQ:NVCR) Cut to Buy at Bid... | 10/25/20 |
| BidaskClub cut shares of Novocure (NASDAQ:NVCR) from a strong-buy rating to a buy rating in a report issued on Thursday morning, BidAskClub reports. A... | |
| Novocure (NASDAQ:NVCR) Stock Rating Lowe... | 10/24/20 |
| Novocure (NASDAQ:NVCR) was downgraded by BidaskClub from a ???strong-buy??? rating to a ???buy??? rating in a research note issued to investors on Thu... | |
| BidaskClub Lowers Novocure (NASDAQ:NVCR)... | 10/24/20 |
| Novocure (NASDAQ:NVCR) was downgraded by investment analysts at BidaskClub from a ???strong-buy??? rating to a ???buy??? rating in a note issued to in... | |
| Novocure (NVCR) to Release Quarterly Ear... | 10/21/20 |
| Novocure (NASDAQ:NVCR) is scheduled to issue its quarterly earnings data before the market opens on Thursday, October 29th. Analysts expect the compan... | |
| Ependymoma Treatment Market Share, Growt... | 10/21/20 |
| Ependymoma Treatment Market report analyzes the market status, market share, current trends, growth rate, future trends, market drivers, opportunities... | |
| Novocure (NASDAQ:NVCR) Upgraded to Stron... | 10/19/20 |
| BidaskClub upgraded shares of Novocure (NASDAQ:NVCR) from a buy rating to a strong-buy rating in a research report released on Friday morning, BidAskC... | |
| What's Behind NovoCure's Recent Gains An... | 10/19/20 |
| Shares of NovoCure have doubled since July '20. The recent gains seem to have been inspired by the company teaming up with pharmaceutical giant, Merck... | |
| The Daily Biotech Pulse: Vertex Pulls Pl... | 10/15/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 14) 10X... | |
| Hold rating | 01/29/21 |
| Truist Securities maintains Hold rating and raises Price Target from $118.00 to $132.00 | |
| Date | 2021-02-25 (BMO) | Est. (EPS/Rev.) | $0.12/ 141.29M |
| Actual (EPS/Rev.) | $0.04/ $143.95 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Burdeshaw Investing | Matthew Burdeshaw | 56.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
